Keybank National Association OH Sells 1,871 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Keybank National Association OH decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 8.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,079 shares of the medical device company’s stock after selling 1,871 shares during the quarter. Keybank National Association OH’s holdings in Cooper Companies were worth $1,938,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Torray Investment Partners LLC raised its holdings in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after purchasing an additional 132 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Cooper Companies by 3.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,151,654 shares of the medical device company’s stock worth $105,872,000 after buying an additional 35,035 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in Cooper Companies by 19.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company’s stock valued at $129,000 after buying an additional 226 shares during the period. Jones Financial Companies Lllp boosted its position in Cooper Companies by 227.7% during the fourth quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company’s stock valued at $89,000 after acquiring an additional 674 shares during the last quarter. Finally, Norden Group LLC grew its holdings in Cooper Companies by 4.7% during the 4th quarter. Norden Group LLC now owns 18,760 shares of the medical device company’s stock worth $1,725,000 after acquiring an additional 838 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Morgan Stanley dropped their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company raised their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $117.22.

Cooper Companies Stock Down 0.4 %

Cooper Companies stock opened at $90.98 on Friday. The firm has a market capitalization of $18.16 billion, a price-to-earnings ratio of 46.66, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The firm’s fifty day moving average price is $92.56 and its two-hundred day moving average price is $99.51. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.